Loading clinical trials...
Loading clinical trials...
A Randomized Double-blind Placebo-controlled Study to Evaluate the Efficacy and Safety of Cinacalcet for the Treatment of Hypercalcemia in Subjects With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy
Conditions
Interventions
Cinacalcet
Placebo
Locations
47
United States
Research Site
Lake Forest, California, United States
Research Site
Lancaster, California, United States
Research Site
Los Gatos, California, United States
Research Site
Mission Viejo, California, United States
Research Site
Orange, California, United States
Research Site
San Diego, California, United States
Start Date
March 10, 2010
Primary Completion Date
July 12, 2012
Completion Date
December 21, 2012
Last Updated
October 17, 2018
NCT04292288
NCT05585593
NCT07099404
NCT07043010
NCT00415584
NCT04299425
Lead Sponsor
Amgen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions